Brief: Vistagen Announces Pricing Of $100 Million Underwritten Offering
Oct 2 (Reuters) - VistaGen Therapeutics Inc VTGN.O :
* VISTAGEN ANNOUNCES PRICING OF $100 MILLION UNDERWRITTEN
OFFERING
* VISTAGEN THERAPEUTICS - OFFERING AT A COMBINED PURCHASE
PRICE OF
$5.38 PER SHARE OF COMMON STOCK, ACCOMPANYING T1 WARRANT AND
ACCOMPANYING T2 WARRANT
Source text for Eikon: ID:nBw5cQWrBa
Further company coverage: VTGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vistagen Therapeutics
See all newsBrief: Vistagen TherapeuticsSays Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VistaGen Q1 revenue rises on licensing agreement expiration
Brief: VistaGen Q1 EPS USD -0.3
Vistagen Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Vistagen Appoints Douglas J. Williamson To Its Board Of Directors